Filter by
Selections
October 20, 2015
Arrowhead Late-Breaker Abstract Accepted for Presentation at the AASLD Liver Meeting 2015
Read MoreOctober 14, 2015
Arrowhead Presents Overview of Its Broad RNAi Delivery Platform and Introduces New Subcutaneously Administered Format
Read MoreSeptember 24, 2015
Arrowhead Reports Peak Reduction in HBsAg of Up to 99% (1.9 log) After a Single Dose with Hepatitis B Candidate ARC-520 in Treatment Naïve Cohort of Phase 2a Study
Read MoreSeptember 11, 2015
Arrowhead Nominates ARC-HIF2 As First RNAi Therapeutic Candidate Using Extrahepatic DPC™ Delivery System
Read MoreSeptember 10, 2015